Combinations for cancer prevention.
Gupta
R A
RA
DuBois
R N
RN
D011125:Adenomatous Polyposis Coli / Q000517:prevention & control*; D000634:Aminoquinolines; D000814:Aniline Compounds; D000818:Animals; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000627:therapeutic use; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D016861:Cyclooxygenase Inhibitors / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D066246:ErbB Receptors / Q000037:antagonists & inhibitors; D051379:Mice; D008954:Models, Biological; D009930:Organic Chemicals; D015398:Signal Transduction / Q000187:drug effects; D013467:Sulindac / Q000627:therapeutic use*
D000634:Aminoquinolines; D000814:Aniline Compounds; D000894:Anti-Inflammatory Agents, Non-Steroidal; D000970:Antineoplastic Agents; D016861:Cyclooxygenase Inhibitors; D009930:Organic Chemicals; D013467:Sulindac; D066246:ErbB Receptors; C413879:EKB 569